University Clinic of Rheumatology, “Ss Ciryl and Methodius” University, Skopje, Republic of Macedonia
Received: 03 October, 2016;Accepted: 07 October, 2016; Published: 08 October, 2016
Dejan Spasovski, University Clinic of Rheumatology, “Ss Ciryl and Methodius” University, Skopje, Republic of Macedonia, Tel: +389023147-668; E-mail:
Spasovski D (2016) Estimate and Evaluation of Drug Nephrotoxicity Caused with Most Used Medicals in Patients with Rheumathoid Arthritis . Arch Clin Nephrol 2(1): 032-037.
© 2016 Spasovski D. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
N-acetyl-β-D-glucosaminidase; Microalbumin; Rheumathoid arthritis; Paracetamol; Ketoprofen
Aim: To estimate the effect of initial therapy with Paracetamol (Acetaminophenum) and nonsteroidal anti-inflamatory drugs (Ketoprofenum) on glomerular and tubular integrity in patients with Rheumatoid arthritis (RA), to quantify toxicity of these drugs through measurements of the enzyme excretion that correlates with the damage degree on the tubular epithelium. Microalbuminuria is used as marker for glomerular damage, and the urinary excretion of N-Acetyl-β-D-glucozaminidase (NAG) as an indicator of proximal tubular damage. To determine if there is a change in the clinical indicators of renal function (serum urea and creatinine, urine urea and creatinine, glomerular filtration rate - GFR) in the course of disease and if that change correlates with the dynamics of the quantity of excreted enzymes in urine, reactants of the acute pfase and index of disease activity (DAS28).
Methods: Using the colorimetric method for determination of NAG, as well as immunoturbidimetric immunoturbidimetric assay for detection of microalbuminuria, we examined samples of 70 participants (35 RA pts treated only with Paracetamol, 35 RA pts treated with Ketoprofen), followed up in five time intervals in the course of 24 weeks. Rheumatoid factor (RF) is determined with the agglutination test (Lateks RF test) in the same participants.
Results: there is a weak correlation between NAG and microalbuminuria (r=0.16) in the group of patients treated with Paracetamol, while in the group treated with Ketoprofen there is moderate correlation (r=0.28). NAG enzymuria in range, in number of examined patients and in time of appearance is greater and appears earlier in the group with Ketoprofen compared with the group of Paracetamol.
Conclusions: Ketoprofen is more potent NAG inductor and triggers greater tubular enzymuria than Parcetamol.
The use of drugs in the treatment of Rheumatoid arthritis (RA) aims to shorten disease duration and prevent complications. Treatment with basic drugs somehow fulfils the expectations. There are a lot of findings recently which show that drugs can damage certain organs caused by their toxic effect due to their accumulation in the organs.
A lot of experiments were realized in the previous two decades aiming to follow the toxic effect of pharmacotherapy to kidneys. These results are used as a base to follow up the influence of drugs in different kidney diseases. In these experiments, beside immunologic, radiologic and cytologic analyses, an important role play also biochemical analyses for detection of certain pathologic conditions caused in the course of treatment.
Among them, determination of enzymes’ and their isoenzymes’ activity in the seum, urine and renal tissue has an important role.
Very often, therapeutic drugs (NSAIDs, Drugs that modify disease activity - DMRADs, Paracetamol, immunosupressive and cytotoxic drugs), can have some nephrotoxic effect. The drug dose very often is not adjusted according to the patient’s condition that can cause some unwanted effects, especially those related to kidney failure due to the their kidney accumulation. This can be seen in long term RA therapy.
Experiments done so far show that there is no indicator, traser or marker that reveals on time the nephrotoxicity caused in the course of disease. Efforts are made to detect these secondary (unwanted) effects by analysis of certain enzyme’s activity in the urine.
Diagnostic and prognostic significance of biotracers
In the contemporary medicine there is a tendency to find the most specific and most sensitive biomarkers as disease indicators and diagnostic tools for follow up of successful treatment.
A lot of investigation has been made in order to choose potential biomarkers that would be important in the clinical practice, giving the best diagnostic information. Especially important were their analytical and clinical application and their cost-benefit.
Useful biomarker has to fulfil some criteria:
1. To have relatively high tissue-specific concentration, and low concentration in other tissues.
2. To be adeqatly distributed subcellularly, so, after the cell damage to be found easily in the examined fluid.
3. To be constant long enough in order to be suitable for following its concentration.
4. To be able to be detected with sensitive analytical methods.
5. To be determined the cut-off values, taking in consideration clinical sensitivity and specificity.
Renal markers for estimation of renal disfunction
Urine enzymes could originate from plasma, lymph nodes of urinary tract, epithelial cells of the urinary tract, white blood cells, red blood cells and kidneys. There are about 40 diffent enzymes belonging to different groups: oxidoreductases, transferases, hydrolases, lyases. Only isomerases and ligases are not found in urine. Such great amount of enzymes in the urine shows the dominant role of the kidney in their exretion.
Several classes of measurable proteins in urine are used for estimation of the nephrotoxicity.
1. Enzyme with high molecular weight, that is not usually filtrated in the glomerul, originating from the proximal tubul (microsomal AAP, NAG, γ-GT)
2. Intermediary proteins that are usually filtrated in the glomerul in very small amounts are reapsorbed in the tubuls in a great amount (microalbumine, transferin).
3. Low moleculare weight proteins that are normaly filtered in the glomerul and are reapsorbed in the tubuls (β2 microglobulin).
According to their subcellular location these enzymes could be devided in membranous (AAP, γ-GT,AF), lysosomal (NAG, β-GLU, β-GAL, lyzozyme), mitohondrial (MDH, γ-LDH), cytoplasmal (LDH). With the development of hystochemistry a detailed insight was made in the enzyme distribution in different nephron structures. Their presence is lower in glomerules than in tubules. The specific enzyme distribution in the nephron enables detection of the spot that is damaged as a sequel of nephrotoxic agents. Examination of the cell membranes of the brush epithelium of the proximal tubules prove the localisation of the alanine amnopeptidase (AAP) in 90%, Alkaline phosphatase (AP) in 70% and γ-glutamyl transpeptidase (γ-GT) in 50% of the whole enzyme activity in the kidney. The examinations reveal that tubular part of the nephrone is rich with enzymes. Brush border is very sensitive in changes in their physiological status, so the release of the superficil enzymes could be used as a marker in primary and secondary renal impairments due to different drugs and toxins [1,2].
Of all the urinary enzymes, U-NAG (urinary) is the most examined. It is the enzyme which belongs in the class of hydrolases present in a great amount in the lysosomes in the proximal tubular cells . In the human body and biological fluids there are two major enzyme forms: A (Acid) i B (Basic) [3-5]. Percentage of A isoform (U-NAG-A) is the greatest in the normal urine [6,7].
At the end of the cell maturational process it is found in solubile form in the citosol. That’s why it’s exretion is connected with the exfoliative turnover and is noted as functional enzymuria. B isoform (U-NAG-B) depends on the matuation and is closely connected with the basal membrane in which it is present. Due to this location of B isoform (U-NAG-B), it is massively released in the tubular lumen only in the case of cytolytic tubular lesion. Its presence in the urine correlates with the cell lysis and is marked as lesion enzymuria [8,9]. NAG could be detected also in the circulation. But, plasma NAG could not pass over intact glomerular membrane because of its high molecular weight (140.000 daltons). For that reason, in healthy individuals the urinary NAG is result of the enzyme amount released from the renal tubulare cells  and is very sensitive marker for renal tubular damage [11-14].
Urine albumin (Microalbuminuria)
Albumin (molecular weight - 66 KDa) is quantitatively the most important plasma and urine protein. Approximately 30% of urine proteins belong to albumin, and it is good indicator for estimation of the changes in glomerular permeability. Such changes happen in patients with diabetic and hypertensive nephropathy, nephritic syndrome, preeclampsia and glomerulonephritis. Urine albumin excretion has high individual variability and depends on the physical activity and food variations. From pathophysiological point of view microalbuminuria could be caused by the increased glomerular permeability for albumin, increased glomerular pressure and/or decreased tubular albumin reabsorption. Renal endothelium is intimately involved in the regulation of these processes [15,16].
Renal impairment due to use of paracetamol and ketoprofen
If drug is transported in proximal tubules via pinocytosis, than the hypothesis that nephrotoxicity is caused by lysosomal disfunction due to the drug precipitation in lysosomes is proved. Vacuols fulfilled with proteins are transported in the middle part of the cell, where they are unite with the existing lysosomes. Hydroltic enzymes catabolize it and the new products are suitable for recirculation.
In the mechanism of Methotraxate nephrotoxicity two moments are very important:
- Active secretion in proximal tubules with the same degree of reapsorption
- Active transport inside the proximal tubules in the antiluminal side with restricted movement of tubular fluids. It is proved that the toxic agent can pass through cell membranes, entering in lysosomes in non-ionised form, so it is trapped in these organels due to the low pH.
Possible mechanism of nephrotoxicity culd be due to interference of the normal lysosomal digestion which leads to lysis of the lysosomal membrane, and tranfer of the acid hydrolazes in the cell cytosol of the proximal tubules, which is manifested latter with necroses.
As possible pathways for entrance in the epithelial cells are noted:
- Apical membrane transportation via pinocytosis with adequate drug uptake (chemotherapeutics, aminoglicosides, cephalosporins, diuretics i other toxic drugs) inside the lysosomes.
- Apical membrane transportation via some unknown way which complements the process of pinocytosis.
- Basolateral membrane transportation.
Material and Methods
The diagnosis of the patients included in the study is based on the revised diagnostic criteria for classification of Rheumatoid arthritis proposed in 1987 by the American Association for Rheumatism (ARA) . In order to include the patient in the group with RA, he should fulfill at least 4 of the 7 criteria. Criteria 1-4 should persist at least 6 months.
In the study are included 35 patients with RA (20 women, 15 men), treated with Paracetamol, and 35 patients with RA (22 women, 13 men) treated with Ketoprofen. Their average age is 55,53 years (±8,42) range (40-65 years), in the group treated with Paracetamol, while 53,24 years (±10,36) range (29-65 years) in the group treated with Ketoprofen. Mean disease duration from the begining is 40,11 months (±40,23 months), range (1-168 months). None of the patients has previous or current hystory of renal disease. None of the patients previously used NSAIDs. Other patients negated use of other drugs such as golden salts, antibiotics or diuretics. Specimens are collected in the period of 2 years.
In the study are included patients with RA, aged 18-65 years, not previously treated with NSAIDs or DMARDs.
From the study are excluded patients with diseases or conditions that could influence results directly or indirectly:
1. Patient younger than 18 years.
2. Patients with previous history of disease of the spleen, thyroid gland, liver, kidneys, hematological, cardiovascular, neurological, autoimmune and lung diseases.
3. Patients with diabetes mellitus, febrile conditions, acute infections, neoplasms.
4. Patients with uric arthritis, SLE, mixed connective tissue disese, vasculitis.
5. Patients with history of blood transfusion and patients with body overweight.
6. Patients with history of use of drugs from the base line.
7. Patients that in 0 point had increase level of glucose, serum ind urine urea and creatinine, blood hypertension, smokers and blood and enzyme disorders
8. Patients previously treated with salycilates, antibiotics, golden salts or diuretics
9. All the patients took part in this study voluntarily, so the ethic criteria for this study are fulfuled.
Clinical estimation of disease activity
Clinical estimation is made by subspecialist in the fild. Disease activity is estimated using DAS 28 index (Disease Activity Score - DAS 28) [18-20]. The index uses mathematical formula to obtain unique composite quantitative score, which consists of: palpabile painful joints (maximal niumber 28), swallen joints (maximal niumber 28), Erythrocyte sedimentation rate (ESR) and patient’s estimation for disease activity (0-100 mm). Visual Analogue Scale - VAS) and morning stiffness (minutes).
DAS 28 index ranges from 0 to 10 and score < 3.2 qualifies the disease as low active.
For clinical estimation of the disease it is necessary to examine following laboratory variables: complete blood count and differencial, reactants of the acute phase, ACPA-antibodies, C-reactive protein (CRP), Rheumatoid factor ( RF ) and Erythrocyte sedimentation rate (ESR), alcaline phosphatase (AP), aspartat aminotransferase (AST), alanin aminotransferase (ALT), creatin kinase (CK), laktat dehydrogenase (LDH), serum urea, serum creatinin. Urine samples are taken not only for rutine analyses, but also for determination of NAG and microalbuminuria.
Detection of microalbuminuria with immunoturbidimetric assay (randox laboratories limited)
Principles: Undissolved sample is added to the puffer with antibodies specific for human serum albumin. The absorbance (340nm) is proportional with the albumin concentration in the urine sample. With the construction of the standard curve from the standard absorbance, one can determine the albumin concentration in the sample. Determination is automatical with the use of DAKO tests.
Urine sample and its storage:
The middle stream from the morning urination is taken. It is centrifuged before the use in order to use purified supernatant.
Referent values: microalbuminuria 2.0-20.0 mg/L.
Determination of the activity of N-acetyl-β-D-glucosaminidase (NAG): colorimetric assay (roche)
Principles: 3-cresol-sulfonphthaleinyl-N-acetyl-β-D-glucosaminide as sodium salt is hydrolyzed from NAG releasing 3-cresol-sulfonephthalein, sodium salt (3-cresol purple) which is measured photometrically on 580nm wavelenght (Roche Mancheim tests). The examined urine is centrifuged and the supernatant is taken.
Referent values: NAG in urine 0.27-1.18 U/mmol creatinine
Serum urea is determined with the method „Kassirer”.
Referent values: serum urea 3 - 7,8 mmol/L.
Serum creatinin is determined with the method „Jaffe”.
Referent values: serum creatinine 45-109 μmol/L; urine creatinine 7-17μmol/dU.
C-reaktiven protein (CRP) is determined with the agglutination assay (Lateks CRP test)(BioSystems S.A. Reagens&Instruments Costa Brava 30, Barcelona, Spain).
Referent values: < 6 mg/L CRP in serum
Rheumatoid factor (RF) is determined with the agglutination assay (Lateks RF test) (BioSystems S.A. Reagens&Instruments Costa Brava 30, Barselona, Spain).
Referent values: < 8 IU/ml inserum.
For determination of the Erythrocyte sedimentation rate (ESR) is used quantitative method - Westergren test.
Referent values are: for men 7-8mm, for women 11-16mm.
To test the significance of the differences between two aritmetical means i.e.proportions is used the Student t-test. To compare the mean values of certain numerical parameters between two groups was used Wilcoxon-matched test for independent species. Sensitivity and predictivity for positive and negative test of the examined markers is determined with the sensitivity and specificity test. P-value between 0.05 and 0.1 is considered statistically significant. Data analysis is performed with statistical package Statistica 7.0.
Analyzing the group of patients treated with Paracetamol in comparison with the distribution of patients according to NAG values in the four samples, one can conclude that NAG values are registered in 20 patients in the 12th week, when the degree of the mean urine NAG value is highest (1.20 ± 1.04) (Table 1) (Figure 1).